Implantable Cardioverter-Defibrillator complication: Difference between revisions

No edit summary
Line 1: Line 1:
==Background==
==Background==
*Approximately 1/3 - 1/2 of ICD patients receive a shock within one year of placement<ref>Sears SF Jr., Shea JB, Conti JB. Cardiology patient page. How to respond to an implantable cardioverter-defibrillator shock. Circulation. 2005;111:e380–e382</ref>
===Nomenclature===
**Generally described as a "kick to the chest"
*All ICDs are also [[pacemaker]]s (i.e. have pacing functionality) but pacemakers are not ICDs (i.e. do not have shocking functionality)
 
===Parts===
*Pulse Generator
**Typically implanted in L upper chest wall
**Contains device hardware and battery
**Acts as a shocking electrode in defibrillation
*Leads
**Insulated and antimicrobial-coated
**Atrial lead
***Pacing and sensing functionality
***Typical bipolar (pacing and sensing are performed by two electrodes, located several millimeters apart at the tip of the lead)
**Right ventricular lead
***Pacing, sensing, and defibrillation functionality
***Has one or two coils to facilitate defibrillation
****Easily identified on Chest X-Ray and can hep differentiate an ICD from a pacemaker
***Typical bipolar (pacing and sensing are performed by two electrodes, located several millimeters apart at the tip of the lead)
**Left Ventricular Lead
***Pacing and sensing functionality
***Bipolar or unipolar (pacing and sensing are performed by one electrode at the tip of the LV lead and a second remote electrode, typically either one of the RV electrodes or the pulse generator)
 
===Indications for ICD implantation===
*Secondary Prevention<ref>Al-Khatib SM et al. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2018;72(14):e91. Epub 2018 Aug 16.</ref>
**Previous episode of unstable VT or VF
***'''Not indicated''' if VT/VF occurs <48 hours after [[myocardial_infarction]]
**Sustained VT in setting of cardiomyopathy or channelopathy
*Primary Prevention<ref>Al-Khatib SM et al. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2018;72(14):e91. Epub 2018 Aug 16.</ref>
**[[Myocardial_infarction]] >40 days ago with LVEF <30%
**[[Cardiomyopathy]] + NYHA Functional Class II or III, and LVEF <35%
***Controversy exists over applying the above criteria to non-ischemic cardiomyopathy
**Patients with underlying disorders placing them at high risk for unstable VT or VF
***Congenital [[long_QT_syndrome]]
***High-risk [[HOCM]]
***[[Brugada_syndrome]]
***[[ARVD]]
***Other channelopathies
*Biventricular ICD (i.e. Cardiac Resynchronization Therapy)
**Any of the above with intraventricular conduction delay of >120ms
 
===Functions===
*Can perform all functions of [[pacemaker]]s
*Anti-tachycardia pacing
**In response to a ventricular rate within a pre-set range (typically ~150-220 bpm), the device will compare the ongoing QRS morphology to a saved image of a QRS complex that is known to be a sinus beat; if the ICD algorithm determines that the ongoing morphology is significantly different (i.e. is unlikely to be a sinus tachycardia), it will deliver a series of paced beats at a rate slightly faster than the ongoing rate in an attempt to break the re-entrant cycle
**A device will typically be programmed to attempt anti-tachycardia pacing several times; if unsuccessful, it will move on to defibrillation
*Defibrillation
**Delivery of a large electrical shock (up to 42 joules) from one electrode to the other in response to VT or VF
**Approximately 1/3 - 1/2 of ICD patients receive a shock within one year of placement<ref>Sears SF Jr., Shea JB, Conti JB. Cardiology patient page. How to respond to an implantable cardioverter-defibrillator shock. Circulation. 2005;111:e380–e382</ref>
**Generally described by patients as a powerful "kick to the chest"
**Can be very distressing and a source of anxiety for patients
**Can be very distressing and a source of anxiety for patients
*Magnet Mode
**Placement of a magnet over the generator will deactivate anti-tachycardia pacing and defibrillation modes as long as the magnet is in place.
*Diagnostics
**Records rhythm strips of AF, VT, and VF episodes for later review
***If anti-tachycardia pacing or defibrillation has occurred, there will be a large alert on the device's interrogation home screen
**Keeps track of % of paced vs intrinsic beats
**Keeps a rate histogram, as well as % of time spent in AF
===Methods to Identify Manufacturer===
*Patient should carry a pocket card indicating manufacturer
*Manufacturer Hotline has patient database
**Medtronic Inc. (1-800-328-2518)
**St. Jude Medical Inc. (recently acquired by Abbott, Inc.) (1-800-722-3774)
**Boston Scientific Inc. (1-800-227-3422)
*Magnet mode
**Does not help differentiate ICDs (different than pacemakers)
===Electromagnetic Interference===
*Nonmedical
**Cell phones: do not interact with device
**Airport security: may trigger alarm, no alteration of activity
*Medical Sources
**[[MRI contraindications|MRI]]: mostly safe, consult cards on device specific recs
**Cardioversion: Use AP pads >8cm from device to minimize adverse effects
**Unipolar Cautery - can cause sensing and pacing malfunction as well as reprogramming


==Clinical Features==
==Clinical Features==

Revision as of 00:50, 10 March 2021

Background

Nomenclature

  • All ICDs are also pacemakers (i.e. have pacing functionality) but pacemakers are not ICDs (i.e. do not have shocking functionality)

Parts

  • Pulse Generator
    • Typically implanted in L upper chest wall
    • Contains device hardware and battery
    • Acts as a shocking electrode in defibrillation
  • Leads
    • Insulated and antimicrobial-coated
    • Atrial lead
      • Pacing and sensing functionality
      • Typical bipolar (pacing and sensing are performed by two electrodes, located several millimeters apart at the tip of the lead)
    • Right ventricular lead
      • Pacing, sensing, and defibrillation functionality
      • Has one or two coils to facilitate defibrillation
        • Easily identified on Chest X-Ray and can hep differentiate an ICD from a pacemaker
      • Typical bipolar (pacing and sensing are performed by two electrodes, located several millimeters apart at the tip of the lead)
    • Left Ventricular Lead
      • Pacing and sensing functionality
      • Bipolar or unipolar (pacing and sensing are performed by one electrode at the tip of the LV lead and a second remote electrode, typically either one of the RV electrodes or the pulse generator)

Indications for ICD implantation

  • Secondary Prevention[1]
    • Previous episode of unstable VT or VF
    • Sustained VT in setting of cardiomyopathy or channelopathy
  • Primary Prevention[2]
  • Biventricular ICD (i.e. Cardiac Resynchronization Therapy)
    • Any of the above with intraventricular conduction delay of >120ms

Functions

  • Can perform all functions of pacemakers
  • Anti-tachycardia pacing
    • In response to a ventricular rate within a pre-set range (typically ~150-220 bpm), the device will compare the ongoing QRS morphology to a saved image of a QRS complex that is known to be a sinus beat; if the ICD algorithm determines that the ongoing morphology is significantly different (i.e. is unlikely to be a sinus tachycardia), it will deliver a series of paced beats at a rate slightly faster than the ongoing rate in an attempt to break the re-entrant cycle
    • A device will typically be programmed to attempt anti-tachycardia pacing several times; if unsuccessful, it will move on to defibrillation
  • Defibrillation
    • Delivery of a large electrical shock (up to 42 joules) from one electrode to the other in response to VT or VF
    • Approximately 1/3 - 1/2 of ICD patients receive a shock within one year of placement[3]
    • Generally described by patients as a powerful "kick to the chest"
    • Can be very distressing and a source of anxiety for patients
  • Magnet Mode
    • Placement of a magnet over the generator will deactivate anti-tachycardia pacing and defibrillation modes as long as the magnet is in place.
  • Diagnostics
    • Records rhythm strips of AF, VT, and VF episodes for later review
      • If anti-tachycardia pacing or defibrillation has occurred, there will be a large alert on the device's interrogation home screen
    • Keeps track of % of paced vs intrinsic beats
    • Keeps a rate histogram, as well as % of time spent in AF

Methods to Identify Manufacturer

  • Patient should carry a pocket card indicating manufacturer
  • Manufacturer Hotline has patient database
    • Medtronic Inc. (1-800-328-2518)
    • St. Jude Medical Inc. (recently acquired by Abbott, Inc.) (1-800-722-3774)
    • Boston Scientific Inc. (1-800-227-3422)
  • Magnet mode
    • Does not help differentiate ICDs (different than pacemakers)

Electromagnetic Interference

  • Nonmedical
    • Cell phones: do not interact with device
    • Airport security: may trigger alarm, no alteration of activity
  • Medical Sources
    • MRI: mostly safe, consult cards on device specific recs
    • Cardioversion: Use AP pads >8cm from device to minimize adverse effects
    • Unipolar Cautery - can cause sensing and pacing malfunction as well as reprogramming

Clinical Features

Differential Diagnosis

Evaluation

Management

Disposition

  • Consider discharge if:
    • Single shock only
    • Currently asymptomatic
    • No concerning associated symptoms (e.g. chest pain, dyspnea, syncope)
  • Admit all others

See Also

External Links

References

  1. Al-Khatib SM et al. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2018;72(14):e91. Epub 2018 Aug 16.
  2. Al-Khatib SM et al. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2018;72(14):e91. Epub 2018 Aug 16.
  3. Sears SF Jr., Shea JB, Conti JB. Cardiology patient page. How to respond to an implantable cardioverter-defibrillator shock. Circulation. 2005;111:e380–e382